A comprehensive review of COVID-19 virology, vaccines, variants, and therapeutics
L Forchette, W Sebastian, T Liu - Current medical science, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of
the coronavirus disease 2019 (COVID-19), has caused more than 179 million infections and …
the coronavirus disease 2019 (COVID-19), has caused more than 179 million infections and …
Flavonoids are promising safe therapy against COVID-19
Flavonoids are a class of phenolic natural products, well-identified in traditional and modern
medicines in the treatment of several diseases including viral infection. Flavonoids showed …
medicines in the treatment of several diseases including viral infection. Flavonoids showed …
Role of nanotechnology behind the success of mRNA vaccines for COVID-19
The emergency use authorization (EUA) by the US-FDA for two mRNA-based vaccines
BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) has brought hope of addressing …
BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) has brought hope of addressing …
Clinical characteristics and pharmacological management of COVID-19 vaccine–induced immune thrombotic thrombocytopenia with cerebral venous sinus …
Importance The COVID-19 pandemic saw one of the fastest developments of vaccines in an
effort to combat an out-of-control pandemic. The 2 most common COVID-19 vaccine …
effort to combat an out-of-control pandemic. The 2 most common COVID-19 vaccine …
A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
20 months has been passed since the detection of the first cases of SARS-CoV-2 infection
named COVID-19 from Wuhan city of China. This novel coronavirus spread rapidly around …
named COVID-19 from Wuhan city of China. This novel coronavirus spread rapidly around …
Allergies and COVID‐19 vaccines: an ENDA/EAACI position paper
Background Anaphylaxis, which is rare, has been reported after COVID‐19 vaccination, but
its management is not standardized. Method Members of the European Network for Drug …
its management is not standardized. Method Members of the European Network for Drug …
The Coronavirus pandemic–2022: Viruses, variants & vaccines
Since the beginning of the COVID-19 pandemic in 2019–2020, Cytokine & Growth Factor
Reviews has published several Special Issues focused on the biology, pathogenesis and …
Reviews has published several Special Issues focused on the biology, pathogenesis and …
Determinants for COVID-19 vaccine hesitancy in the general population: a systematic review of reviews
Aim Although multiple COVID-19 vaccines are approved for global use, vaccine hesitancy
poses a substantial risk for global health. Therefore, the aim of this umbrella review is to …
poses a substantial risk for global health. Therefore, the aim of this umbrella review is to …
A summary of the SARS-CoV-2 vaccines and technologies available or under development
ZA Abdulla, SM Al-Bashir, NS Al-Salih, AA Aldamen… - Pathogens, 2021 - mdpi.com
Since the beginning of 2020, the world has been in a race to develop vaccines that can
control the COVID-19 pandemic. More than 250 projects have been initiated for this …
control the COVID-19 pandemic. More than 250 projects have been initiated for this …
Targeting COVID vaccine hesitancy in rural communities in Tennessee: implications for extending the COVID-19 pandemic in the South
DJ Alcendor - Vaccines, 2021 - mdpi.com
Approximately 40% of Tennesseans are vaccinated fully, due mainly to higher vaccination
levels within urban counties. Significantly lower rates are observed in rural counties …
levels within urban counties. Significantly lower rates are observed in rural counties …